Life Clips, Inc. Stocks

$ 0Last Updated 23.03.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

$ 1794

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
$ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Life Clips, Inc. develops, finances, produces, and distributes artificial intelligence (AI) based technological solutions for the mental health and healthcare sector in the United States. The company offers AI powered mental health analytics platform for businesses to measure, understand, and improve the mental well-being of their employees, patients, or customers. Its products include Yuru 3-in-1 tool, a personal mental health monitor that screens early signs of mental health conditions, such as stress and depression.; and Aiki, an AI-based intuitive mental health ChatBot. The company also offers cryptocurrency exchanges and blockchain development services; body cameras; auditable software solution for law enforcement; and single-use and cordless batteries under the Mobeego brand for use in cellular phones and other mobile devices. Life Clips, Inc. was incorporated in 2013 and is based in Aventura, Florida.

Company Valuation

Greatly overvalued
1/7

Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks